MTOR and cancer: pS6, the active form of the effector S6 for PI3K/mTOR signaling, and phosho-ERK (pERK), the active form of the effector ERK for mitogen-activated protein kinase (MAPK) signaling, are upregulated in HPV-associated cancers according to previous reports [12,13,50,51].